KOE · 094170.KQ
Dongwoon Anatech Co., Ltd.
₩19,130-₩970 (-4.83%)
Dongwoon Anatech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 66.08% below the high.
Loading market information…
KOE · 144510.KQ · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Gc Cell Corp.’s quoted price sits in the lower half of its reported 52-week range, 64.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Gc Cell Corp.’s forward annual dividend is ₩100 per share, paid annual. The forward yield is 0.99% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Gc Cell Corp.’s next earnings report is currently expected on Nov 12, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Gc Cell Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
GC Cell Corp. engages in the research and development of cell curing agents and in the transport and sale of consignment inspection samples. It offers cell therapy products, cell banking, clinical laboratory services, clinical trials, and bio logistics. The company was founded on June 21, 2011, and is headquartered in Yongin-si, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:35 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2024 | Oct 31, 2024 | ₩683 | ₩45.35B-6.11% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩19,130-₩970 (-4.83%)
Dongwoon Anatech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 66.08% below the high.
₩18,470-₩1,140 (-5.81%)
AbClon Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.72% below the high.
₩16,470-₩740 (-4.3%)
Neuromeka Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 82.23% below the high.
₩11,970-₩720 (-5.67%)
T-Robotics.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 61.26% below the high.
₩17,580-₩1,220 (-6.49%)
ADTechnology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.65% below the high.
₩3,200-₩210 (-6.16%)
Bio Plus Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 51.0% below the high.
₩9,060-₩590 (-6.11%)
LOT VACUUM Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.5% below the high.
₩4,050-₩80 (-1.94%)
JEIO Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 74.43% below the high.
